Weekend reading: How GLP-1 drugs are affecting food companies

Alert to readers: Amazon.com displays listings for several more workbooks, study guides, and cookbooks purportedly based on my book, What to Eat Now (see previous post on this).  I did not write any of them.  Caveat emptor!

___________________________

I’ve been collecting items on the effects of GLP-1 drugs on the food industry.

Recall my mantra: Eating less is bad for business.

These drugs are a threat to the food industry.  Here’s how it is responding.

• New research from Chemi Nutra highlights how GLP-1 users want to maintain the benefits of the medication while feeling like their former selves, revealing a significant gap in addressing the broader physiological and psychological impacts of weight loss meds…. Listen now
• The GLP-1 effect: How 2026 will look for food and beverage:  From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to the rise of GLP-1 users… Listen now
• GLP-1: Threat or opportunity for food manufacturers?  At this early stage in the market, not all manufacturers know how to respond… Read more  
• GLP-1 adoption is rising steadily – and reshaping pack size, portfolio strategy and volume.  Rising GLP-1 adoption is quietly reshaping pack size strategy, category risk and marketing priorities for food and beverage brands… Read more  
• Five ways GLP-1 drugs are shaping the beverage industry:  Soda sales are taking a hit; but functional beverages are booming… Read more
• GLP-1 has changed the snack game: Here’s how to win it back:  GLP-1 users are rewriting the rules of appetite, texture and indulgence. Tate & Lyle’s latest research shows exactly where producers are missing the moment… Read more
• Could functional foods replace the need for GLP-1s?  As GLP-1 drugs disrupt the weight loss market, food and beverage players are racing to unlock the appetite-regulating power of functional ingredients… Read more